Navigation Links
'Disprin Plus' is now 'Disprin Paracetamol'

Reckitt Benckiser has deferred the launch of 'Disprin CV' (cardiovascular) following the confusion over the name of its new painkiller 'Disprin Plus', the company's Regional Director , Mr. Pranab Barua said. The company also announced a change in the brand-name 'Disprin Plus' to 'Disprin Paracetamol'. Subsequent to the launch of Disprin Plus, there were reports citing instances of concern from doctors and consumers regarding the use of the suffix 'Plus' along with the brand-name, Mr. Barua said.

"This matter was also taken up by the drug aythorities and the company was advised to address this concern.// Taking cognisance of the concern of consumers and the drug authorities, the company decided to change the suffix from 'Plus' to 'Paracetamol', thereby making clear the brand's ingredient ," he said.

Mr. Barua said that the company, which had an inventory of 15 - 20 million tablets worth about Rs 1 crore, will suffer loss of sale for a month during the transition period to the tune of Rs 1.5 - 2 crore. Disprin 'Paracetamol' will be in the market by mid-December , he said. The company has also decided not to give any brand push to Disprin Cold and Flu for similar reasons, Mr. Baura said.

Paracetamol-based Disprin 'Plus' was launched by Reckitt Benckiser (India) in August this year to replace Disprin (350 mg aspirin) in the pain relief segment. Mr. Barua said Disprin CV (100 mg aspirin) will not be launched till the new brand 'Disprin Paracetamol' is completely established.


'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves drug for rare liver disease
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. New spray gel heals surgical wounds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... financial services firm serving the families and businesses of the Norwalk and ... program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology: